The Enterprise Value as of November 2024 (TTM) for Demant A/S (WILYY) is 69.09B

According to Demant A/S’s latest financial reports and current stock price. The company's current Enterprise Value is 69.09B. This represents a change of 55.52% compared to the average of 44.42B of the last 4 quarters.

Demant A/S (WILYY) Historical Enterprise Value (quarterly & annually)

How has WILYY Enterprise Value performed in the past?

The mean historical Enterprise Value of Demant A/S over the last ten years is 34.13B. The current 69.09B Enterprise Value has changed 20.14% with respect to the historical average. Over the past ten years (40 quarters), WILYY's Enterprise Value was at its highest in in the June 2021 quarter at 52.26B. The Enterprise Value was at its lowest in in the June 2015 quarter at 17.18B.

Demant A/S (WILYY) Enterprise Value by Quarter and Year

Discovering the peaks and valleys of Demant A/S Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Demant A/S (WILYY) Average Enterprise Value

How has WILYY Enterprise Value performed in the past?

The current Enterprise Value of Demant A/S (WILYY) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages

Demant A/S (WILYY) Enterprise Value vs. Peers

How is WILYY’s Enterprise Value compared to its peers?

Demant A/S’s Enterprise Value is greater than Cochlear Limited (18.47B), greater than GN Store Nord A/S (30.94B), greater than GN Store Nord A/S (32.55B), greater than Siemens Healthineers AG (68.20B), greater than Sonova Holding AG (20.27B), greater than CONMED Corporation (3.08B), greater than iCAD, Inc. (26.30M), greater than Tivic Health Systems, Inc. (-1899758.00), greater than Talis Biomedical Corporation (-37931750.00), greater than Bluejay Diagnostics, Inc. (-6409922.00), greater than Heart Test Laboratories, Inc. (-834267.00), greater than Nuwellis, Inc. (4.84M), greater than CVRx, Inc. (277.88M), greater than Hyperfine, Inc. (16.79M), greater than Inogen, Inc. (134.14M), greater than Accelerate Diagnostics, Inc. (78.10M), greater than Apyx Medical Corporation (46.21M),

Build a custom stock screener for Demant A/S (WILYY) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Demant A/S using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Demant A/S (WILYY) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Demant A/S or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.